Co-development

Innovation is at the heart of everything we do at Douglas. Our experience in product development has enabled us to create a portfolio of successful therapies that have made a real difference in patients’ lives.

Douglas has a robust portfolio of innovative projects in various therapeutic areas. We’re seeking co-development partners with complementary expertise and resources to accelerate the development and commercialisation of these promising therapies.

Why partner with Douglas?

We offer a unique blend of expertise, resources, and a proven track record of success, making us an ideal partner for co-development ventures. Here’s what sets us apart.

Strong technical capability
With over 58 years of experience in pharmaceutical development, manufacturing, and commercialisation, we possess the knowledge and insights to navigate the complexities of the healthcare landscape.
Deep institutional knowledge
The scientists and formulators who developed our products are still on the team at Douglas. This continuity provides an unparalleled depth of understanding and ensures that the original vision for each product is maintained and enhanced.
State-of-the-art facilities
Our GMP-certified manufacturing plant and advanced research laboratories, and access to clinical research trial teams provide the infrastructure necessary to support projects from concept to commercialisation.
Wide networks
We have experience with regulators across the globe and have established a robust distribution network in 50 countries.
Commitment to quality
Douglas is renowned for adherence to the highest international quality standards, ensuring the safety and efficacy of all our products.
Flexible partnership models
We understand that every project is unique. We offer flexible partnership models tailored to your specific needs and objectives.
Shared vision
We’re committed to building long-term, mutually beneficial partnerships based on trust, transparency, and open communication.

Our pipelines

505(j) Complex Generic Pipeline

Douglas has several projects in the pre-formulation or formulation development stage.

Douglas specialises in specialty generic product development such as soft-gelatin capsules that have technical, clinical or IP complexity.

505(b)(2) Pipeline

Douglas specialises in the development of 505(b)(2) alternative formulation products to meet unmet needs in populations of paediatric, geriatric and patients with swallowing difficulties.

We are open to collaboration on these oral liquid opportunities focusing on the US market.

Our 505(j) Pipeline

Our 505(b)(2) Pipeline

Co-development

Why partner with Douglas?

Our pipelines

Our 505(j) Pipeline

Our 505(b)(2) Pipeline

Contact us about your co-development opportunity

Co-development

Why partner with Douglas?

Our 505(j) Pipeline

Our 505(b)(2) Pipeline

Contact us about your co-development opportunity